Categories
- Arts & Entertainment
- Business
- Communications
- Computers
- Culture & Society
- Disease & Illness
- Fashion
- Finance
- Food & Beverage
- Health & Fitness
- Hobbies
- Home & Family
- Home Based Business
- Internet Business
- Legal
- Pets & Animals
- Politics
- Product Reviews
- Recreation & Sports
- Reference & Education
- Religion
- Self Improvement
- Shopping
- Travel & Leisure
- Vehicles
- Writing & Speaking
Information
Biotechnology Timeline: Important Events And Discoveries In Biotechnology
Submitted: 2007-01-17 16:26:36
Print this article | Tell a friend | For publisher |
1977:
The Age of biotechnology arrives with “somatostatin” - a human growth hormone-releasing inhibitory factor, the first human protein manufactured in bacteria by Genentech, Inc. A synthetic, recombinant gene was used to clone a protein for the first time.
1978:
Genentech, Inc. and The City of Hope National Medical Center announce the successful laboratory production of human insulin using recombinant DNA technology. Hutchinson and Edgell show it is possible to introduce specific mutations at specific sites in a DNA molecule.
1979:
Sir Walter Bodmer suggests a way of using DNA technology to find gene markers to show up specific genetic diseases and their carriers. John Baxter reports cloning the gene for human growth hormone.
1980:
The prokaryote model, E. coli, is used to produce insulin and other medicine, in human form. Researchers successfully introduce a human gene - one that codes for the protein interferon- into a bacterium. The U.S. patent for gene cloning is awarded to Cohen and Boyer.
1981:
Scientists at Ohio University produce the first transgenic animals by transferring genes from other animals into mice. The first gene-synthesizing machines are developed. Chinese scientists successfully clone a golden carp fish.
1982:
Genentech, Inc. receives approval from the Food and Drug Administration to market genetically engineered human insulin. Applied Biosystems, Inc. introduces the first commercial gas phase protein sequencer.
1983:
The polymerase chain reaction is invented by Kary B Mullis. The first artificial chromosome is synthesized, and the first genetic markers for specific inherited diseases are found.
1984:
Chiron Corp. announces the first cloning and sequencing of the entire human immunodeficiency virus (HIV) genome. Alec Jeffreys introduces technique for DNA fingerprinting to identify individuals. The first genetically engineered vaccine is developed.
1985:
Cetus Corporation's develops GeneAmp polymerase chain reaction (PCR) technology, which could generate billions of copies of a targeted gene sequence in only hours. Scientists find a gene marker for cystic fibrosis on chromosome number 7.
1986:
The first genetically engineered human vaccine - Chiron's Recombivax HB - is approved for the prevention of hepatitis B. A regiment of scientists and technicians at Caltech and Applied Biosystems, Inc. invented the automated DNA fluorescence sequencer.
1987:
The first outdoor tests on a genetically engineered bacterium are allowed. It inhibits frost formation on plants. Genentech's tissue plasminogen activator (tPA), sold as Activase, is approved as a treatment for heart attacks.
1988:
Harvard molecular geneticists Philip Leder and Timothy Stewart awarded the first patent for a genetically altered animal, a mouse that is highly susceptible to breast cancer
1989:
UC Davis scientists develop a recombinant vaccine against the deadly rinderpest virus. The human genome project is set up, a collaboration between scientists from countries around the world to work out the whole of the human genetic code.
1990:
The first gene therapy takes place, on a four-year-old girl with an immune-system disorder called ADA deficiency. The human genome project is formally launched.
1991:
Mary-Claire King, of the University of California, Berkeley, finds evidence that a gene on chromosome 17 causes the inherited form of breast cancer and also increases the risk of ovarian cancer. Tracey the first transgenic sheep is born.
1992:
The first liver xenotransplant from one type of animal to another is carried out successfully. Chiron's Proleukin is approved for the treatment of renal cell cancer.
1993:
The FDA declares that genetically engineered foods are "not inherently dangerous" and do not require special regulation. Chiron's Betaseron is approved as the first treatment for multiple sclerosis in 20 years.
1994:
The first genetically engineered food product, the Flavr Savr tomato, gained FDA approval. The first breast cancer gene is discovered. Genentech's Nutropin is approved for the treatment of growth hormone deficiency.
1995:
Researchers at Duke University Medical Center transplanted hearts from genetically altered pigs into baboons, proving that cross-species operations are possible. The bacterium Haemophilus influenzae is the first living organism in the world to have its entire genome sequenced.
1996:
Biogen's Avonex is approved for the treatment of multiple sclerosis. The discovery of a gene associated with Parkinson's disease provides an important new avenue of research into the cause and potential treatment of the debilitating neurological ailment.
1997:
Researchers at Scotland's Roslin Institute report that they have cloned a sheep--named Dolly--from the cell of an adult ewe. The FDA approves Rituxan, the first antibody-based therapy for cancer.
1998:
The first complete animal genome the C.elegans worm is sequenced. James Thomson at Wisconsin and John Gearhart in Baltimore each develop a technique for culturing embryonic stem cells.
1999:
A new medical diagnostic test will for the first time allow quick identification of BSE/CJD a rare but devastating form of neurologic disease transmitted from cattle to humans.
2000:
"Golden Rice," modified to make vitamin A. Cloned pigs are born for the first time in work done by Alan Coleman and his team at PPL, the Edinburgh-based company responsible for Dolly the sheep.
2001:
The sequence of the human genome is published in Science and Nature, making it possible for researchers all over the world to begin developing genetically based treatments for disease.
2002:
Researchers sequence the DNA of rice, and is the first crop to have its genome decoded.
2003:
The sequencing of the human genome is completed.
Biotechnology HQ http://biotechnology-hq.com/ articles and information about the science of biotechnology.
Article source: Expert Articles
Most Recent Articles in Science category
- The Z-Boson Mass and its Formula as Multiple Proofs in One Bowl of Yummy Pudding - By: Sean Sheeter
A demonstration of the mathematical, theoretical and, especially, empirical connotations of the phrase "Pudding Proof" in the context of a highly exacting physical model. In particular, a formula is given deriving the mass of the Z-boson from two heavy quarks and and Higgs field. Remarkably, the precise correlation with the known value of the Z-mass is thus empirically proof positive of these far less directly measurable masses, which is further supported by arithmetic and theoretic construct. - The Theory, Significance and Precise Calculation of Gluino Mass - By: Sean Sheeter
A preview of the most significant predictable particle cascades at Cern's LH-Collider in the coming years. Describes how a precise gluino mass of 6.388355 TeV relates to the super-symmetric Higgs mechanism and decays to squarks and other 'sparticles as a prerequisite to creation of 'dark mass,' as well as the unsolved puzzle of material baryon creation. Which also goes on to shows why giving three dimensionless calculations for the gluino mass are central to the e-course "241-Mumbers." - Derivation of the Pure Precise Fine-Structure Number and as a Ratio of Two Inexact Metric Constants - By: Sean Sheeter
A history of a definitive answer to #1 'millennium question' of Strings 2000 in regard to whether all fundamental parameters can be determined in a dimensionless manner. Focus's on a 'pure' calculation of the fine-structure constant from a unified 'monolithic' system that allows precise equations for the full spectrum of fundamental particle masses from Higgs/SUSY to quarks, neutrinos and dark matter. With an update on controversies of determining the fine-structure from metric measures and a few other related issues. - Proof of the Exact Up and Down Quark Masses from the Pion Mass-Differential - By: Sean Sheeter
A discussion of the equivalence of the mass differential between the charged and neutral pion as a function the mass difference between the down and up quark. Given the unprecedented mass value of the down quark = 7.763258 MeV, the up quark mass is calculable from the even more exacting d-u mass differential = 4.593453 MeV, where the experimental pion mass difference = 4.5936 plusmn.0005 MeV. - Camps that Grow the Science in You - By: Ron Victor
If science is your child's much loved subject in the school, then it would be very worthful if you enroll him or her in any of the best science camp during summer vacation. - Why Are Some Scientists Doubtful about Subliminal Influence? - By: Evgheny Stivenson
Does subliminal perception really occur? Can anyone be able to observe something involuntarily without being conscious about it? These questions were raised to challenge the scientific validity of such claims. Experiments were conducted to prove that subliminal perception was indeed a fact. - Windmill site selection using Remote Sensing and GIS - A case Study in Andaman India - By: K Selvavinayagam
Windmills are a major source of renewable energy. Erection of windmills promotes development of industry, tourism and other coastal infrastructure facilities. Predominant wind direction and wind power density is noticed in Andaman Group of Islands such as North Andaman, Middle Andaman, South Andaman, Little Andaman and Teressa Island is Southwest. In order to sustain the environment in an eco-friendly manner, windmill site selection is carried out in North Passage Island, Andaman. - Methodology for Assessment of Natural Hazard Vulnerability in U.S. Coastal Zone Using Remote Sensing - By: K Selvavinayagam
U.S. coastal counties face severe meteorological hazards as compared to any other country in the Earth. Hence in order to formulate a methodology for the quantitative assessment of natural hazard vulnerability due to climate change, the study is attempted. Recent scientific tools such as remote sensing and GIS were integrated. Methodology for developing site specific models for the study is strategically planned and executed. - ShoreLine Change Monitoring in Tuticorin Coast - India, Using Remote Sensing and GIS Tools - By: K Selvavinayagam
Erosion and accretion along the Tuticorin coast were identified using Landsat 5 TM May 1993, IRS P2 LISS II May 1996 and IRS 1C LISS III May 2002 data in comparison with Survey of India toposheet no L1 & L5 (1969) as baseline data. Geomorphic study of Tuticorin coast showed that the entire coastline is prograding and the coastal process that has been taking place is similar as noticed from IRS P2 1996, IRS 1C 2001 and IRS 1C 2002 satellite imageries. - Disaster Management Practices Using ArcGIS, ArcIMS, ArcSDE and SQL - By: K Selvavinayagam
Emergency preparedness for disaster management is a crucial segment wherein administrators, planners, managers and stakeholders play an important role. For emergency preparedness and disaster management the dynamic representation of spatial and aspatial data in a web enabled GIS environment is the mark of the day. Dynamic representation of spatial and aspatial data, inputting data from client side and identifying its pros and cons, planning/decision making upon the information/data collected.
